These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1720907)

  • 1. [The value of prostate-specific antigen].
    Wirth M
    Urologe A; 1991 May; 30(3 Suppl):6. PubMed ID: 1720907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

  • 3. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic intraepithelial neoplasia and prostate-specific antigen.
    Brawer MK
    Urology; 1989 Dec; 34(6 Suppl):62-5. PubMed ID: 2481364
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic intraepithelial neoplasia: significance and correlation with prostate-specific antigen and transrectal ultrasound. Proceedings of a workshop of the National Prostate Cancer Detection Project. March 13, 1989, Bethesda, Maryland.
    Urology; 1989 Dec; 34(6 Suppl):2-69. PubMed ID: 2481359
    [No Abstract]   [Full Text] [Related]  

  • 7. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.
    Cooner WH
    Invest Radiol; 1989 Mar; 24(3):257-9. PubMed ID: 2473962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Misleading figures concerning PSA and health examination].
    Fager PJ
    Lakartidningen; 1991 Sep; 88(38):3065-6. PubMed ID: 1717799
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.
    Lee F; Torp-Pedersen ST; Carroll JT; Siders DB; Christensen-Day C; Mitchell AE
    Urology; 1989 Dec; 34(6 Suppl):4-8. PubMed ID: 2481362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "hook effect": high concentrations of prostate-specific antigen giving artifactually low values on one-step immunoassay.
    Wolf BA; Garrett NC; Nahm MH
    N Engl J Med; 1989 Jun; 320(26):1755-6. PubMed ID: 2471931
    [No Abstract]   [Full Text] [Related]  

  • 12. [The detection of cancer of the prostate. Challenge for the 1990s?].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(6):385-7. PubMed ID: 2464966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the serum determination of specific prostatic antigen in the prediction of prostatic cancer].
    Morote Robles J; Ruibal Morell A; Pont Salvadó A
    Actas Urol Esp; 1988; 12(1):10-4. PubMed ID: 2455436
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostatic secretory products as markers of prostatic neoplasms.
    Purvis K; Mevåg B; Teige B; Torjesen P; Jakobsen H; Rui H; Attramadal A
    APMIS Suppl; 1988; 2():224-37. PubMed ID: 2460112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostatic-specific antigen].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(3):159-60. PubMed ID: 2456711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?].
    Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D
    Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate-specific antigen in adenocarcinoma of the prostate.
    N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
    [No Abstract]   [Full Text] [Related]  

  • 20. Ratio of polyclonal-monoclonal prostate-specific antigen levels. Discrimination of nodal status in prostate tumors that produce low marker levels.
    Stephenson RA; Greskovich FJ; Fritsche HA; James BC
    Urol Clin North Am; 1991 Aug; 18(3):467-71. PubMed ID: 1715103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.